Last Updated on October 30, 2018 by Joseph Gut – thasso October 31, 2018 – The American Food and Drug Administration (FDA)  recently approved Cemiplimab-Rwlc (Libtayo) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell …

Hope for patients with cutaneous squamous cell carcinoma (CSCC): Cemiplimab-Rwlc (Libtayo) Read more »

Last Updated on October 22, 2018 by Joseph Gut – thasso October 21, 2018 – In a study published online September 13 in JAMA Oncology, the authors just reminded us of the fact that besides all hype about immune checkpoint inhibitors …

Cancer therapies: Immune checkpoint inhibitors may kill you Read more »